Quick Answer
Edesa Biotech, Inc. reported Stockholders Equity of $12.45 million for the year ending 2025.
- Edesa Biotech, Inc. showed an increase of +528.5% in Stockholders Equity from 2024 to 2025.
- This data is from Edesa Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on December 12, 2025.
- XBRL data for this metric is available from 2012 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $6.54 million | Q4 2014: $9.24 million | Q1 2015: $8.92 million | Q2 2015: $9.43 million | Q4 2015: $9.63 million | Q1 2016: $8.81 million | Q2 2016: $7.66 million | Q4 2016: $10.86 million | Q1 2017: $9.79 million | Q2 2017: $8.60 million | Q3 2017: $7.40 million | Q4 2017: $6.02 million | Q1 2018: $4.74 million | Q2 2018: $12.39 million | Q3 2018: $3.55 million | Q1 2019: $2.77 million | Q2 2019: $6.21 million | Q4 2019: $4.23 million | Q1 2020: $6.93 million | Q2 2020: $5.34 million | Q4 2020: $7.89 million | Q1 2021: $19.27 million | Q2 2021: $15.80 million | Q4 2021: $10.55 million | Q1 2022: $17.02 million | Q2 2022: $11.84 million | Q4 2022: $10.27 million | Q1 2023: $9.00 million | Q2 2023: $7.85 million | Q4 2023: $5.84 million | Q1 2024: $4.32 million | Q2 2024: $2.87 million | Q3 2024: $1.98 million | Q4 2024: $2.26 million | Q1 2025: $15.54 million | Q2 2025: $14.13 million | Q3 2025: $12.45 million | Q4 2025: $13.95 million.
- Over the full 16 years of available data (2012 to 2025), Edesa Biotech, Inc.'s Stockholders Equity has grown by 1,280.2%.
- Historical annual values: Fiscal year 2025: $12.45 million | Fiscal year 2024: $1.98 million | Fiscal year 2023: $7.05 million | Fiscal year 2022: $9.39 million | Fiscal year 2021: $13.06 million | Fiscal year 2020: $6.63 million | Fiscal year 2019: $5.26 million | Fiscal year 2018: $3.21 million | Fiscal year 2018: $11.29 million | Fiscal year 2017: $7.40 million | Fiscal year 2016: $12.31 million | Fiscal year 2015: $8.01 million | Fiscal year 2014: $10.46 million | Fiscal year 2014: $7.70 million | Fiscal year 2013: -$2.20 million | Fiscal year 2012: $902.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: